Jonathan Griggs Net Worth

The estimated Net Worth of Jonathan Griggs is at least $70.3 Thousand dollars as of 31 May 2017. Mr. Griggs owns over 8,000 units of Cumberland Pharmaceuticals stock worth over $14,585 and over the last 14 years he sold CPIX stock worth over $55,760. In addition, he makes $0 as Independent Director at Cumberland Pharmaceuticals.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Griggs CPIX stock SEC Form 4 insiders trading

Jonathan has made over 2 trades of the Cumberland Pharmaceuticals stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 8,000 units of CPIX stock worth $55,760 on 31 May 2017.

The largest trade he's ever made was selling 8,000 units of Cumberland Pharmaceuticals stock on 31 May 2017 worth over $55,760. On average, Jonathan trades about 580 units every 51 days since 2010. As of 31 May 2017 he still owns at least 10,803 units of Cumberland Pharmaceuticals stock.

You can see the complete history of Mr. Griggs stock trades at the bottom of the page.

Jonathan Griggs biography

Jonathan I. Griggs serves as Independent Director of the Company. has served as a member of our Board of Directors since 2010. His career spans more than 41 years in the pharmaceutical and biotechnology industries and includes significant international experience. He spent 23 years at Warner Lambert Corporation in positions of increasing responsibility, culminating with his position as Vice President of Human Resources. During his tenure with Warner Lambert, he provided leadership for the successful integration of three pharmaceutical businesses into what became Parke Davis, the largest consolidation in the industry at that time. From 1992 to present he has been the CEO of Griggs & Associates, a management and human resources consulting firm assisting start-up companies and providing critical assistance in turnaround situations. Mr. Griggs also provided the leadership and strategic management for the formation and establishment of the AACA (Antique Auto Club of America) Museum, a leading transportation museum where he served as chairman and is currently a director. Mr. Griggs has his B.S. Degree from Penn State and attended the Wharton School of Management at the University of Pennsylvania. He has been an advisor to Cumberland Pharmaceuticals as a member of the company’s Pharmaceutical Advisory Board since it began operations in 1999. The Board of Directors believes Mr. Griggs’ experience in strategic management and human resources consulting will be critical as the company continues to build a strong, effective management team.

How old is Jonathan Griggs?

Jonathan Griggs is 85, he's been the Independent Director of Cumberland Pharmaceuticals since 2010. There are no older and 19 younger executives at Cumberland Pharmaceuticals.

What's Jonathan Griggs's mailing address?

Jonathan's mailing address filed with the SEC is 2525 WEST END AVENUE, SUITE 950, NASHVILLE, TN, 37203.

Insiders trading at Cumberland Pharmaceuticals

Over the last 15 years, insiders at Cumberland Pharmaceuticals have traded over $4,393,644 worth of Cumberland Pharmaceuticals stock and bought 265,077 units worth $1,208,228 . The most active insiders traders include Joey A Jacobs, Leo Pavliv, and Thomas R Lawrence. On average, Cumberland Pharmaceuticals executives and independent directors trade stock every 29 days with the average trade being worth of $10,407. The most recent stock trade was executed by Caroline Young on 1 December 2022, trading 379 units of CPIX stock currently worth $849.

What does Cumberland Pharmaceuticals do?

cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.

Complete history of Mr. Griggs stock trades at Cumberland Pharmaceuticals

Cumberland Pharmaceuticals executives and stock owners

Cumberland Pharmaceuticals executives and other stock owners filed with the SEC include:

• A. Kazimi,
  Chairman of the Board, Chief Executive Officer
• A. J. Kazimi,
  Founder, Chairman, Pres & CEO
• Leo Pavliv,
  Executive Vice President - Operations, Chief Development Officer
• Leo B. Pavliv,
  Exec. VP of Operations & Chief Devel. Officer
• Martin Cearnal,
  Executive Vice President, Chief Commercial Officer, Director
• Martin E. Cearnal,
  Exec. VP, Chief Commercial Officer & Director
• James Herman,
  Vice President - National Accounts, Chief Compliance Officer
• James Lowrance Herman,
  Sr. VP of National Accounts & Chief Compliance Officer
• Michael Bonner,
  Senior Director Finance and Accounting and Chief Financial Officer
• Caroline Young,
  Independent Director
• Kenneth Krogulski,
  Independent Director
• James Jones,
  Independent Director
• Joey Jacobs,
  Independent Director
• Jonathan Griggs,
  Independent Director
• Joseph Galante,
  Independent Director
• Gordon Bernard,
  Independent Director
• Erin Smith Gull,
  Sr. Corp. Relations Associate
• Adam S. Mostafa,
  Managing Director
• Cindy B. Patton,
  Sr. Director of Field Marketing
• Jean W. Marstiller,
  Sr. VP of Admin. Services & Corp. Sec.
• John Michael Hamm,
  Director of Fin. & Accounting and CFO
• Thomas R Lawrence,
  Director
• Martin S Jr Brown,
  
• Chris T. Bitterman,
  Vice Pres Sales & Marketing
• Rick Scott Greene,
  Chief Financial Officer
• Robert Edwards,
  Director
• Jean W Marstiller,
  Sr. VP & Corp. Secretary
• Lawrence W Greer,
  Director
• David L Lowrance,
  Vice President and CFO
• Todd M. Anthony,
  Vice Pres Organizational Dev
• John M. Hamm,
  VP Chief Financial Officer